Latin America Biodefense Market Size & Outlook, 2021-2030

The biodefense market in Latin America is expected to reach a projected revenue of US$ 227.8 million by 2030. A compound annual growth rate of 5.4% is expected of Latin America biodefense market from 2022 to 2030.
Revenue, 2021 (US$M)
$141.5
Forecast, 2030 (US$M)
$227.8
CAGR, 2022 - 2030
5.4%
Report Coverage
Latin America

Latin America biodefense market highlights

  • The Latin America biodefense market generated a revenue of USD 141.5 million in 2021.
  • The market is expected to grow at a CAGR of 5.4% from 2022 to 2030.
  • In terms of segment, anthrax was the largest revenue generating product in 2021.
  • Radiation/nuclear is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, Mexico is expected to register the highest CAGR from 2022 to 2030.


Latin America data book summary

Market revenue in 2021USD 141.5 million
Market revenue in 2030USD 227.8 million
Growth rate5.4% (CAGR from 2021 to 2030)
Largest segmentAnthrax
Fastest growing segmentRadiation/nuclear
Historical data covered2018 - 2020
Base year for estimation2021
Forecast period covered2022 - 2030
Quantitative unitsRevenue in USD million
Market segmentationAnthrax, Small Pox, Botulism, Radiation/nuclear
Key market players worldwideAltimmune Inc, Emergent BioSolutions Inc, Dynavax Technologies, SIGA Technologies Inc, Elusys Therapeutics, Ichor Medical Systems, Cleveland-Cliffs Inc, Bavarian Nordic A/S, Ology Bioservices, Alnylam Pharmaceuticals Inc, XOMA


Other key industry trends

  • In terms of revenue, Latin America region accounted for 1.0% of the global biodefense market in 2021.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 1,455.9 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Biodefense Market Companies

Name Profile # Employees HQ Website

Latin America biodefense market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biodefense market will help companies and investors design strategic landscapes.


Anthrax was the largest segment with a revenue share of 27.49% in 2021. Horizon Databook has segmented the Latin America biodefense market based on anthrax, small pox, botulism, radiation/nuclear covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Latin America biodefense market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Latin America biodefense market databook

  • Our clientele includes a mix of biodefense market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America biodefense market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America biodefense market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Latin America biodefense market size, by country, 2018-2030 (US$M)

Latin America Biodefense Market Outlook Share, 2021 & 2030 (US$M)

Latin America biodefense market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more